Both companies may succeed in this industry.
This biotech has candidates in late-stage clinical development.
Erasca stock fell Monday despite no company news, after reports said Merck ended acquisition talks with cancer drugmaker ...
Zacks Investment Research on MSN
ANIP vs. TEVA: Which drug stock is the better buy right now?
Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and ...
Investor's Business Daily on MSN
Eli Lilly stock rebounds as weight-loss drug battle continues
Eli Lilly stock has been climbing back from a recent pullback and nearing a buy point. The drugmaker teamed up with Nvidia on ...
Revolution Medicines shares drop after Merck buyout talks collapse over price. Deal was valued at $28-32B before negotiations ...
Merck & Company Inc (NYSE:MRK) has ceased discussions to acquire biotechnology firm Revolution Medicines Inc (NASDAQ:RVMD), following a failure to reach an agreement on the company’s valuation.
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...
Roth's $212 price target implies an additional upside of 32% for shares of Insmed, which have already rallied 160% in the last 12 months.
Swiss bank UBS reports that the White House may reach a deal with GLP-1 weight loss drug producers Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) to adjust their pricing lower for U.S. customers.
6d
Stock Market Today, Jan. 20: Corvus Pharmaceuticals Surges After Positive Phase 1 Eczema Drug Data
Early eczema trial success and heavy trading are rapidly reshaping how investors view this drug developer, today, Jan. 20, 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results